This federal contract award, with an ID of SPE2DB20D1100|SPE2DB25FZ18M, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,030.14 firm fixed-price delivery order is for the supply of OPZELURA 1.5% Cream, a pharmaceutical product, with a completion date of November 22, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award, with ID SPE2DB22D3004|SPE2DB24FPK03, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OPZELURA 1.5% cream, a pharmaceutical product, with a ceiling value of $2,578.87 and a completion date of February 21, 2024. The contract is a Delivery Order under a Firm Fixed Price pricing type. This award is not designated as a set-aside...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OPZELURA 1.5% Cream, a pharmaceutical product, with a ceiling value of $9,076.42 and a completion date of June 10, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,164.79 firm-fixed-price delivery order is for the supply of OPZELURA 1.5% cream, a pharmaceutical product, with a completion date of July 19, 2024. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp is the prime contractor and holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award, valued at $10,319.11, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OPZELURA 1.5% CREAM 60GM, a medical product, with a completion date of May 19, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,757.38 firm fixed-price delivery order is for the supply of OPZELURA 1.5% Cream in 60-gram sizes. The contract has an ultimate completion date of March 26, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $19,275.47 and a completion date of December 10, 2024. It is a firm fixed-price contract for the delivery of OPZELURA 1.5% Cream, a pharmaceutical product. The contract is not set aside for any specific business designation. AmerisourceBergen holds a significant Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The contract, valued at $17,293.59, is for the delivery of OPZELURA 1.5% Cream in 60 gram packaging. The order is a firm fixed-price contract with a completion date of July 17, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OPZELURA 1.5% Cream, a pharmaceutical product, with a ceiling value of $1,539.12 and a completion date of April 1, 2024. This contract is a firm fixed-price delivery order, with no set-aside requirements. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award, with ID SPE2DB20D3103|SPE2DB24FP7B3, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,634.68, is for the delivery of OPZELURA 1.5% CREAM 60GM, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an Ultimate Completion Date of July 31, 2024. The contract was awarded on July 30, 2024 and...